Switzerland's Sonova H1 revenue rises, lifts FY outlook

By Reuters News


Overview

  • Switzerland hearing care provider's H1 revenue rose 7.5% in local currencies to CHF 1.83 bln

  • Core EBIT for H1 rose 22.9% in local currencies, reflecting strong operating leverage and cost discipline

  • Company raised full-year 2026/27 guidance for sales and core EBIT growth


Outlook

  • Sonova raises full-year sales growth outlook to 6–8% from 5–8%, in local currencies

  • Company lifts full-year core EBIT growth guidance to 10–13% from 7–10%, in local currencies

  • Sonova expects currency translation to be broadly neutral for sales and core EBIT growth in FY 2026/27


Result Drivers

  • HEARING INSTRUMENTS GROWTH - Strong sales in Hearing Instruments, led by Wholesale and Retail, drove overall revenue gains

  • NEW PRODUCT LAUNCHES - Launches of EON, Roger On Sphere and Integro supported market share gains and sales growth

  • COST DISCIPLINE - Improved profitability attributed to strong operating leverage and disciplined cost management


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

CHF 1.83 bln


Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy", 10 "hold" and 3 "sell" or "strong sell"

  • The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

  • Wall Street's median 12-month price target for Sonova Holding AG is CHF259.00, about 8.4% below its November 11 closing price of CHF282.80

  • The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 20 three months ago


Reuters Recommended Reads

  • Nov 11 - Alcon shares fall as tighter eye-care market outlook raises growth concerns

  • Nov 10 - Denmark's Lundbeck posts higher Q3 profit, raises FY revenue and EBITDA guidance

  • Nov 10 - Switzerland's Alcon Q3 sales slightly miss estimates despite surgical equipment launches, vision care growth


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.